Boeing Has Selected Two Engine Types For Boeing 7E7 Dreamliner

Boeing has selected two engine types, the General Electric GENX and Rolls-Royce Trent 1000, for its all-new Boeing 7E7 Dreamliner.

Boeing's decision follows months of collaboration with the leading manufacturers of large commercial airplane engines. "The General Electric and Rolls-Royce engines will enable the 7E7 to fly higher, faster, farther, cleaner, quieter and more efficiently than comparable airplanes," said 7E7 Senior Vice President Mike Bair. "Having an engine choice is a key consideration for our customers. We're now offering two excellent options for the 7E7."

Both engine types will be capable of providing between 55,000 and 70,000 lbs. of thrust, which will allow the three planned 7E7 models to use the same basic engines. The 7E7 will reduce fuel use, and associated emissions, by 20 percent over today's comparably sized airplanes.

The engines are key contributors to the airplane's dramatic efficiency improvements. The engines will also help the 7E7 be significantly quieter than today's airplanes and meet new industry requirements. "All three engine manufacturers presented exceptional proposals," Bair said. "We reached this major milestone well ahead of our original schedule due to the close collaboration on requirements, capabilities and technologies. While it was a challenging decision, the speed with which we made it is representative of the customer interest and the overall momentum on the 7E7 program."

For the first time in commercial jet history, both engine types will use the same standard interface with the airplane, allowing any 7E7 twinjet to be fitted with either engine at any point in time. Engine interchangeability makes the 7E7 a flexible asset that can easily be moved among carriers, an attractive feature for financiers, leasing companies and airlines.

Other 7E7 innovations include the elimination of traditional bleed air systems in favor of an efficient, more-electric architecture. General Electric's new engine, called the GENX (GE Next Generation), is derived from the ultra-high-thrust GE90 engine, which has a proven track record on twin-engine aircraft. The GENX technologies include composite fan blades, the highest pressure-ratio compressor in aviation, and a unique single-annular combustor (where compressed air and fuel are mixed) to achieve dramatically lower emissions. The GENX will have its first full-engine test in 2006.

The engine is being designed and tested at GE Transportation's world headquarters in Evendale, Ohio. Final assembly will occur in Durham, N.C. "Our engine for the 7E7 represents the culmination of new technologies for which GE has made considerable investments over many years," said David Calhoun, president and CEO of GE Transportation. "Needless to say, this is one of the biggest days in the history of our jet engine business." Rolls-Royce will produce a new variant of its successful, high-thrust Trent engine series to power the 7E7, the Trent 1000.

Designed to deliver optimum performance with minimum development risk, it will be the fifth member of the Trent family to enter service, once again featuring the three-shaft design layout unique to Rolls-Royce. The engine will be the most efficient and environmentally advanced Trent ever built. Mike Terrett, president of Civil Aerospace for Rolls-Royce, said, "This is a special day in the long and rewarding relationship between our companies. Now, once again, our focus is on bringing a new generation of Trent successfully to market." Boeing is continuing to receive strong customer support for the 7E7 and has submitted a number of firm contract proposals to airlines.

The company expects to launch the new airplane this year.

For more information on jet engines

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.